Hot Pursuit     14-Feb-25
Anupam Rasayan rises after Q3 PAT zooms 108% YoY to Rs 54 cr
Anupam Rasayan India rose 2.41% to Rs 687.60 after the company's consolidated net profit surged 108.33% to Rs 54.21 crore on a 32.02% jump in revenue from operations to Rs 390.14 crore in Q3 FY25 over Q3 FY24.
Profit before tax stood at Rs 59.50 crore in Q3 FY25, registering the growth of 65.74%, compared with Rs 35.90 crore posted in the corresponding quarter last year.

EBITDA (including other income) was at Rs 120.8 crore in Q3 FY25 from Rs 81.5 crore in Q3 FY24, registering the growth of 48.22% year on year. EBITDA margin improved 31% in Q3 FY25 from 27% in Q3 FY24.

Total expense jumped 24.85% year on year to Rs 327.09 crore during the quarter. Cost of materials consumed stood at Rs 272.68 crore (up 85.12% YoY), while employee benefits expense was at Rs 20.09 crore (down 20.09% YoY) during the period under review.

On a 9-month basis, the company's consolidated net profit declined 23.57% to Rs 97.04 crore on 12.64% drop in revenue from operations to Rs 938.30 crore in 9M FY24 over 9M FY23.

Meanwhile, the company announced that it has signed a Letter of Intent (LOI) with a US-based multinational corporation worth Rs 1,697 crore to supply a high-performance specialty chemical used in critical polymer applications. The supply of this product will span the next 10 years.

Speaking on the performance, Anand Desai, managing director of Anupam Rasayan, commented, “Our Pharma and Polymer segments, which have emerged as key growth drivers, continue to strengthen their contribution to our revenue.

Both segments, coupled with the strong performance of Tanfac, led to significant growth this quarter, fueling a robust 31% QoQ revenue growth in Q3 FY25 on a consolidated basis. For the full year, we expect them to play a substantial role in overall revenue, with this upward trend projected to continue into FY26. Additionally, the agrochemical segment has shown signs of recovery, particularly in the European market.

With strong demand momentum and expected off-take from our customers, we anticipate regaining our growth trajectory in the next financial year, aiming for a 30–35% revenue increase in FY26."

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science-related specialty chemicals, comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives.

Previous News
  Anupam Rasayan India consolidated net profit declines 59.03% in the September 2024 quarter
 ( Results - Announcements 15-Nov-24   15:50 )
  Board of Anupam Rasayan India allots 19.04 lakh shares to promoter entity
 ( Corporate News - 19-Dec-23   11:48 )
  Anupam Rasayan India announces board meeting date
 ( Corporate News - 11-Aug-25   11:19 )
  Anupam Rasayan rises after Q4 PAT climbs 44% YoY to Rs 45 cr
 ( Hot Pursuit - 26-May-25   11:11 )
  Volumes jump at Anupam Rasayan India Ltd counter
 ( Hot Pursuit - 06-Jun-24   14:30 )
  Board of Anupam Rasayan India recommends Final Dividend
 ( Corporate News - 18-May-24   17:12 )
  Anupam Rasayan India standalone net profit rises 12200.00% in the June 2021 quarter
 ( Results - Announcements 06-Aug-21   12:28 )
  Anupam Rasayan India consolidated net profit rises 13865.22% in the June 2021 quarter
 ( Results - Announcements 06-Aug-21   12:30 )
  Anupam Rasayan gains on signing LoI with Japanese firm
 ( Hot Pursuit - 23-Mar-23   11:35 )
  Anupam Rasayan signs supply agreement with European crop protection company
 ( Corporate News - 17-Oct-22   11:12 )
  Anupam Rasayan India to convene board meeting
 ( Corporate News - 23-May-22   10:50 )
Other Stories
  BMW Ventures bags Rs 4-cr order from leading PSU
  18-Nov-25   17:21
  Oriental Rail bags coupler supply contract from Eastern Railways
  18-Nov-25   17:14
  Wonderla Holidays to launch park in Chennai
  18-Nov-25   16:18
  WeWork India climbs after foreign brokerage initiates coverage with 'Buy'
  18-Nov-25   15:40
  Greaves Cotton joins hands with Ligier Group
  18-Nov-25   15:24
  Praveg bags LoA from Gujarat tourism for new resort project in Kutch
  18-Nov-25   15:18
  Glenmark Pharma gets EC nod for acne drug Winlevi in 15 European countries
  18-Nov-25   15:16
  Transformers & Rectifiers India Ltd leads losers in 'A' group
  18-Nov-25   15:00
  Atal Realtech Ltd leads losers in 'B' group
  18-Nov-25   14:45
  Volumes spurt at Bombay Burmah Trading Corporation Ltd counter
  18-Nov-25   14:30
Back Top